Clinical Trial Update: Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED [NA]

View source ↗

Summary

Northwestern University is leading a trial protocol to improve diagnostic safety for fatty liver disease by identifying steatosis, risk stratification, and ED r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease
• Non-alcoholic Fatty Liver Disease
• Steatosis of the Liver

Snippet

Sponsor: Northwestern University | Conditions: Non-Alcoholic Fatty Liver Disease, Steatosis of Liver | NA | Status: NOT_YET_RECRUITING